Preferences of bereaved family members on communication with physicians when discontinuing anticancer treatment. - Referring to the concept of nudges

Author:

YOSHIDA Saran1,HIRAI Kei2,OHTAKE Fumio2,MASUKAWA Kento3,MORITA Tatsuya4,KIZAWA Yoshiyuki5,TSUNETO Satoru6,SHIMA Yasuo7,MIYASHITA Mitsunori3

Affiliation:

1. Tohoku University

2. Osaka University

3. Tohoku University Graduate School of Medicine

4. Seirei Mikatahara General Hospital

5. University of Tsukuba

6. Kyoto University Graduate School of Medicine

7. Tsukuba Medical Center Hospital

Abstract

Abstract Purpose: This study aimed to clarify the situation and evaluate the communication on anticancer treatment discontinuation from the viewpoint of a bereaved family, in reference to the concept of nudges. Methods: A multi-center questionnaire survey was conducted involving 350 bereaved families of patients with cancer admitted to palliative care units in Japan. Results: The following explanations were rated as essential or very helpful: 1) anticancer treatment would be a physical burden for the patient (43.1%), 2) providing anticancer treatment was impossible (40.6%), 3) the disadvantages of undergoing treatment (40.6%), 4) not having the treatment would be better for the patient (40.6%), and 5) the advantages of not having the treatment (40.3%). The factors associated with a high need for improvement of the physician’s explanation included older age of the participant (β = 0.221, p = 0.010); lack of explanation that anticancer treatment cannot be given (β = 0.219, p = 0.001); and lack of explanation on the specific benefits of not having treatment (β = 0.251, p = 0.001). Conclusion: Explaining the disadvantages of continuing anticancer treatment and the advantages of discontinuing treatment and presenting treatment discontinuation as the default option were effective in helping patients’ families in making the decision to discontinue treatment. In particular, explanation regarding the benefits of treatment discontinuation and show the discontinuation of anticancer treatment as the default option was considered important, as the lack of them caused a higher need for improvement.

Publisher

Research Square Platform LLC

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3